All lobbying filings

Brownstein Hyatt Farber Schreck, LLP

Brownstein Hyatt Farber Schreck, LLP filed a Q1 report for Harmony Biosciences on April 15, 2026, reporting $50,000 in lobbying income.

Lobbying for Harmony Biosciences · Biopharmaceutical company

As filed: BROWNSTEIN HYATT FARBER SCHRECK, LLP for HARMONY BIOSCIENCES.

All filings by Brownstein Hyatt Farber Schreck, LLP · Everything Harmony Biosciences has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 15, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 1

HOUSE OF REPRESENTATIVES

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to the development and approval of therapies for rare diseases Pharmaceutical tariffs

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.